“To study serum phospholipase a2 in sepsis And non-sepsis patients at kle’s dr.Prabhakar kore hospital & mrc, cross sectional one year study belagavi.”

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1523

Full metadata record

DC Field	Value	Language
dc.contributor.author	REGNO:BG0120020	-
dc.date.accessioned	2023-10-18T06:42:27Z	-
dc.date.available	2023-10-18T06:42:27Z	-
dc.date.issued	2023-10	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1523	-
dc.description.abstract	Background: A dysregulated host response to infection results in sepsis, and severe organ failure that puts life in danger. Phospholipase A2 is a new marker in diagnosis of sepsis and is also elevated in infections. Hardly few studies were done regarding the biomarker especially regarding its capacity to diagnose sepsis. The objective of the current study was to measure the phospholipase A2 levels in sepsis patients and contrast them with their procalcitonin levels.	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.subject	sepsis, septic shock, non sepsis, phospholipase A2, procalcitonin, serum lactate, blood culture, gram positive and gram negative blood culture	en_US
dc.title	“To study serum phospholipase a2 in sepsis And non-sepsis patients at kle’s dr.Prabhakar kore hospital & mrc, cross sectional one year study belagavi.”	en_US
dc.type	Dissertations	en_US
Appears in Collections:	General Medicine MD

Files in This Item:

File	Description	Size	Format
BG0120020.pdf		2.3 MB	Adobe PDF	View/Open